Improving Access to Psychological Therapies in Spain: From IAPT to PsicAP

  1. Antonio Cano-Vindel 1
  2. Paloma Ruiz-Rodríguez 2
  3. Juan A. Moriana 3
  4. Leonardo Adrián Medrano 4
  5. César González-Blanch 5
  6. Elisa Aguirre 6
  7. Roger Muñoz-Navarro 7
  1. 1 Universidad Complutense de Madrid
    info

    Universidad Complutense de Madrid

    Madrid, España

    ROR 02p0gd045

  2. 2 Centro de Salud Castilla La Nueva, Servicio Madrileño de Salud
  3. 3 Universidad de Córdoba
    info

    Universidad de Córdoba

    Córdoba, España

    ROR https://ror.org/05yc77b46

  4. 4 Pontifi cia Universidad Católica Madre y Maestra
  5. 5 Hospital Universitario Marqués de Valdecilla - IDIVAL
  6. 6 NELFT NHS Foundation Trust IAPT Service
  7. 7 Universitat de València
    info

    Universitat de València

    Valencia, España

    ROR https://ror.org/043nxc105

Mostrar afiliaciones +
Revista:
Psicothema

ISSN: 0214-9915,  1886-144X

Año de publicación: 2022

Volumen: 34

Número: 1

Páginas: 18-24

Tipo: Artículo

DOI: 10.7334/PSICOTHEMA2021.113 DIALNET GOOGLE SCHOLAR lock_openAcceso abierto editor

Otras publicaciones en: Psicothema

Resumen

Background: Anxiety and depression are very prevalent in primary care, with high rates of chronic cases, comorbidity and lost quality of life, along with huge economic costs. The Improving Access to Psychological Therapies (IAPT) project, launched in the United Kingdom in 2007, has become an international benchmark for the treatment of common mental disorders. In Spain, Psicofundación developed the PsicAP clinical trial, following the precedent set by the IAPT. Method: This study reviews and compares and contrasts the methods, results, and contributions of the IAPT and PsicAP. Results: The IAPT is a project for the pragmatic implementation of evidence-based psychological therapies in primary care. PsicAP is a randomized clinical trial whose results demonstrated that adding a psychological treatment (seven group sessions of transdiagnostic cognitive-behavioural therapy) to treatment-as-usual (TAU) for anxiety and depression in the primary care setting was more effective and cost-effective than TAU alone. The therapeutic gains and the cost-effectiveness were maintained at a 12 months follow-up. Moreover, the percentage of reliably recovered patients was comparable to the numbers from the IAPT. Conclusions: This brief psychological treatment should be implemented in the Spanish public health system, similar to the precedent set by the IAPT initiative

Referencias bibliográficas

  • Aragonès, E., López-Cortacans, G., Sánchez-Iriso, E., Piñol, J. L., Caballero, A., Salvador-Carulla, L., & Cabasés, J. (2014). Cost-effectiveness analysis of a collaborative care programme for depression in primary care. Journal of Affective Disorders, 159, 85-93. https://doi.org/10.1016/j.jad.2014.01.021
  • Cano-Vindel, A. (2011). Bases Teóricas y Apoyo Empírico de la Intervención Psicológica Sobre Los Desórdenes Emocionales en Atención Primaria. Una Actualización [Theoretical Bases and Empirical Support for Psychological Intervention on Emotional Disorders in Primary Care. An update.]. Ansiedad y Estrés, 17(2-3), 157-184.
  • Cano-Vindel, A., Muñoz-Navarro, R., Moriana, J. A., Ruiz-Rodríguez, P., Medrano, L. A., & González-Blanch, C. (2021). Transdiagnostic group cognitive behavioral therapy for emotional disorders in primary care: The results of the PsicAP randomized controlled trial. Psychological Medicine, 1-13. https://doi.org/10.1017/S0033291720005498
  • Clark, D. M. (2018). Realizing the mass public benefit of evidence-based psychological therapies: The IAPT program. Annual Review of Clinical Psychology, 14, 159-183. https://doi.org/10.1146/annurev-clinpsy050817-084833
  • Clark, D. M., Layard, R., Smithies, R., Richards, D. A., Suckling, R., & Wright, B. (2009). Improving access to psychological therapy: Initial evaluation of two UK demonstration sites. Behaviour Research and Therapy, 47(11), 910-920. https://doi.org/10.1016/j.brat.2009.07.010
  • Codony, M., Alonso, J., Almansa, J., Vilagut, G., Domingo, A., Pinto-Meza, A., Fernández, A., Serrano-Blanco, A., Márquez, M., & Haro, J. M. (2007a). Uso de fármacos psicotrópicos en España. Resultados del estudio ESEMeD-España [Psychotropic medications use in Spain. Results of the ESEMeD-Spain study]. Actas Españolas de Psiquiatría, 35(2), 29-36.
  • Codony, M., Alonso, J., Almansa, J., Vilagut, G., Domingo, A., Pinto-Meza, A., Fernández, A., Usall, J., Dolz, M., & Haro, J. M. (2007b). Utilización de los servicios de salud mental en la población general española. Resultados del estudio ESEMeD-España [Mental health care use in the Spanish general population. Results of the ESEMeD-Spain study]. Actas Españolas de Psiquiatría, 35(2), 21-28
  • Cromarty, P., Drummond, A., Francis, T., Watson, J., & Battersby, M. (2016). NewAccess for depression and anxiety: Adapting the UK Improving Access to Psychological Therapies Program across Australia. Australasian Psychiatry, 24(5), 489-492. https://doi. org/10.1177/1039856216641310
  • Cross, S. P., & Hickie, I. (2017). Transdiagnostic stepped care in mental health. Public Health Research & Practice, 27(2), e2721712. http:// dx.doi.org/10.17061/phrp2721712
  • Cuijpers, P., Quero, S., Dowrick, C., & Arroll, B. (2019). Psychological Treatment of Depression in Primary Care: Recent Developments. Current Psychiatry Reports, 21(12), 129. https://doi.org/10.1007/ s11920-019-1117-x
  • De Girolamo, G., Alonso, J., & Vilagut, G. (2006). The ESEMeDWMH project: Strenghtening epidemiological research in Europe through the study of variation in prevalence estimates. Epidemiology and Psychiatric Sciences, 15(3), 167-173. https://doi.org/10.1017/ S1121189X00004401
  • Gili, M., García Campayo, J., & Roca, M. (2014). Economic crisis and mental health. SESPAS report 2014. Gaceta Sanitaria, 23(1), 103-108. https://doi.org/10.1016/j.gaceta.2014.02.005
  • González-Blanch, C., Umaran-Alfageme, O., Cordero-Andrés, P., MuñozNavarro, R., Ruiz-Rodríguez, P., Medrano, L. A., Ruiz-Torres, M., Dongil Collado, E., & Cano-Vindel, A. (2018). Psychological treatment of emotional disorders in Primary Care: The transdiagnostic treatment manual of the PsicAP study. Ansiedad y Estrés, 24(1), 1-11. https://doi. org/10.1016/j.anyes.2017.10.005
  • Haro, J. M., Palacín, C., Vilagut, G., Martínez, M., Bernal, M., Luque, I., Codony, M., Dolz, M., & Alonso, J. (2006). Prevalence of mental disorders and associated factors: Results from the ESEMeD-Spain study. Medicina Clínica, 126(12), 445-451. https://doi.org/10.1157/13086324
  • Jacobson, N.S., & Truax, P. (1991). Clinical significance: A statistical approach to defi ning meaningful change in psychotherapy research. Journal of Consulting and Clinical Psychology, 59, 12-19.
  • Knapstad, M., Lervik, L. V., Sæther, S. M. M., Aarø, L. E., & Smith, O. R. F. (2020). Effectiveness of Prompt Mental Health Care, the Norwegian Version of Improving Access to Psychological Therapies: A Randomized Controlled Trial. Psychotherapy and Psychosomatics, 89(2), 90-105. https://doi.org/10.1159/000504453
  • Kobori, O., Nakazato, M., Yoshinaga, N., Shiraishi, T., Takaoka, K., Nakagawa, A., Iyo, M., & Shimizu, E. (2014). Transporting cognitive behavioral therapy (CBT) and the improving access to psychological therapies (IAPT) project to Japan: Preliminary observations and service evaluation in Chiba. Journal of Mental Health Training, Education and Practice 9(3), 155-166. https://doi.org/10.1108/JMHTEP-10-2013- 0033
  • Layard, R., & Clark, D. M. (2015). Why more psychological therapy would cost nothing. Frontiers in Psychology, 6, 1713. https://doi.org/10.3389/ fpsyg.2015.01713
  • Ministry of Health, Consumer Affairs, and Social Welfare (2019). Strategic Framework for Primary and Community Care. Publication center.
  • Moriana, J. A., Gálvez-Lara, M., & Corpas, J. (2017). Psychological treatments for mental disorders in adults: A review of the evidence of leading international organizations. Clinical Psychology Review, 54, 29-43. https://doi.org/10.1016/j.cpr.2017.03.008
  • Muñoz-Navarro, R., Cano-Vindel, A., Ruiz-Rodríguez, P., Medrano, L. A., González-Blanch, C., Moriana, J. A., Capafons Bonet, A., & Dongil-Collado, E. (2017). Diagnostic and referral hierarchical model of common mental disorders in primary care centers. The PsicAP clinical trial approach. Ansiedad y Estrés, 23(2-3), 124-129. https://doi. org/10.1016/j.anyes.2017.10.002
  • Naeem, F., Pikard, J., Rao, S., Ayub, M., & Munshi, T. (2017). Is it possible to provide low-intensity cognitive behavioral treatment (CBT Lite) in Canada without additional costs to the health system? Firstyear evaluation of a pilot CBT Lite program. International Journal of Mental Health, 46(4), 253-268. https://doi.org/10.1080/00207411.201 7.1345039
  • National Institute for Health and Care Excellence (NICE) (2011). Common mental health disorders: identifi cation and pathways to care. https:// www.nice.org.uk/guidance/CG113
  • Organization for Economic Co-operation and Development (2015). OECD Health Data: Pharmaceutical market, OECD Health Statistics (database). https://doi.org/10.1787/Data-00545-En
  • Parés-Badell, O., Barbaglia, G., Jerinic, P., Gustavsson, A., Salvador-Carulla, L., & Alonso, J. (2014). Cost of disorders of the brain in Spain. PLoS ONE, 9(8), e105471. https://doi.org/10.1371/journal.pone.0105471
  • Polanin, J. R., & Snilstveit, B. (2016). Converting between effect sizes. Campbell Systematic Reviews, 12(1), 1-13. https://doi. org/10.4073/cmpn.2016.3
  • Richards, D. A., & Suckling, R. (2009). Improving access to psychological therapies: Phase IV prospective cohort study. The British Journal of Clinical Psychology, 48(Pt 4), 377-396. https://doi. org/10.1348/014466509X405178
  • Roca, M., Gili, M., García-García, M., Salva, J., Vives, M., Campayo, J. G., & Comas, A. (2009). Prevalence and comorbidity of common mental disorders in primary care. Journal of Affective Disorders, 119(1-3), 52- 58. https://doi.org/10.1016/j.jad.2009.03.014
  • Rovira, J., Albarracín, G., Salvador, L., Rejas, J., Sánchez-Iriso, E., & Cabasés, J. M. (2012). The cost of generalized anxiety disorder in primary care settings: Results of the ANCORA study. Community Mental Health Journal, 48(3), 372-383. https://doi.org/10.1007/ s10597-012-9503-4
  • Ruiz-Rodríguez, P. (2019). Análisis de coste-efectividad y coste-utilidad del tratamiento cognitivo-conductual de los desórdenes emocionales en Atención Primaria frente a tratamiento convencional [Cost-effectiveness and cost-utility analysis of the cognitive-behavioral treatment of emotional disorders in Primary Care compared to conventional treatment]. Universidad Complutense de Madrid.
  • Ruiz-Rodríguez, P., Cano-Vindel, A., Muñoz-Navarro, R., Wood, C. M., Medrano, L. A., Moretti, L. S., & PsicAP Research Group (2018). Cost-Effectiveness and Cost-Utility Analysis of the Treatment of Emotional Disorders in Primary Care: PsicAP Clinical Trial. Description of the Sub-study Design. Frontiers in Psychology, 9, 281. https://doi. org/10.3389/fpsyg.2018.00281
  • Ruiz-Rodríguez, P., Cano-Vindel, A., Muñoz Navarro, R., Medrano, L., Moriana, J. A., Buiza Aguado, C., Jiménez Cabré, G., & González-Blanch, C. (2017). A systematic review and critique of the economic impact and burden of common mental disorders in Spain. Ansiedad y Estrés, 23(2), 118-123. https://doi.org/10.1016/j.anyes.2017.10.003
  • Salari, N., Hosseinian-Far, A., Jalali, R., Vaisi-Raygani, A., Rasoulpoor, S., Mohammadi, M., Rasoulpoor, S., & Khaledi-Paveh, B. (2020). Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic: A systematic review and metaanalysis. Globalization and Health, 16(1), 1-11. https://doi.org/10.1186/ s12992-020-00589-w
  • Wakefield, S., Kellett, S., Simmonds-Buckley, M., Stockton, D., Bradbury, A., & Delgadillo, J. (2021). Improving Access to Psychological Therapies (IAPT) in the United Kingdom: A systematic review and meta-analysis of 10-years of practice-based evidence. British Journal of Clinical Psychology, 60(1), 1-37. https://doi.org/10.1111/bjc.12259
  • Whiteford, H. A., Ferrari, A. J., Degenhardt, L., Feigin, V., & Vos, T. (2015). The global burden of mental, neurological and substance use disorders: An analysis from the global burden of disease study 2010. PLoS ONE, 10(2), e0116820. https://doi.org/10.1371/journal.pone.0116820
  • World Health Organization (2017). Depression and other common mental disorders: Global health estimates. World Health Organization. https:// doi.org/WHO/MSD/MER/2017.2
  • Zhang, A., Borhneimer, L. A., Weaver, A., Franklin, C., Hai, A. H., Guz, S., & Shen, L. (2019). Cognitive behavioral therapy for primary care depression and anxiety: A secondary meta-analytic review using robust variance estimation in meta-regression. Journal of Behavioral Medicine, 42(6), 1117-1141. https://doi.org/10.1007/s10865-019- 00046-z
Fuente de los datos: Dialnet